Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ryotaro Ikeguchi
When and How Disease-Modifying Drugs for Multiple Sclerosis Should Be Changed in Daily Practice
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Related publications
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Archives of Neurology
Disease Modifying Treatments and Symptomatic Drugs for Cognitive Impairment in Multiple Sclerosis: Where Do We Stand?
Multiple Sclerosis and Demyelinating Disorders
Allergy
Immunology
Neurology
Multiple Sclerosis Disease-Modifying Therapy and Pregnancy
Multiple Sclerosis
Neurology
Disease‐modifying Drugs for Multiple Sclerosis in Japan: A Focus on the 2017 Japanese Guidelines and the 2018 Supplement
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy
Acta Neurologica Scandinavica
Medicine
Neurology
Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
When and How Should Subcentimetric Lung Nodules Be Referred for Operation?
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
CPR Guidelines Should Be Changed
BMJ
The Association of Adherence to Disease-Modifying Drugs and Out-Of-Pocket Costs in Patients With Multiple Sclerosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental